Plain-English translation of NCT07421739 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a companion study to a larger clinical trial testing a medication called bel-sar for choroidal melanoma (a type of eye cancer). Instead of testing the medication itself, this study focuses on understanding how bel-sar treatment impacts your everyday life—including your ability to do daily activities, how you manage symptoms, and your overall well-being. Your real-world perspective will help researchers understand the full impact of this treatment.
While clinical trials measure whether a medication works medically, they don't always capture what matters most to patients: how treatment affects your daily life and quality of life. This study exists to fill that gap by listening directly to people being treated for eye melanoma about their actual experiences.
You likely qualify if…
You likely don't qualify if…
You will complete online surveys through a secure link on your smartphone, laptop, or tablet. You'll answer questions about your symptoms, daily activities, and overall health and well-being—similar to a questionnaire you might fill out at a doctor's visit. This will happen over a period of up to 24 months (2 years), and you can complete the surveys from home at your own pace.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Australia
Collaborators
Vitaccess Ltd
Enrollment target
~15 participants
Started
November 2025
Primary completion
August 2028
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Medical Monitor
Aura Biosciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.